Skip to main content
Log in

Structure–activity studies of Ti(IV) complexes: aqueous stability and cytotoxic properties in colon cancer HT-29 cells

  • Original Paper
  • Published:
JBIC Journal of Biological Inorganic Chemistry Aims and scope Submit manuscript

Abstract

As part of our research efforts in the area of titanium-based antitumor agents, we have investigated the cytotoxic activity of [Ti4(maltolato)8(μ-O)4], (Cp-R)2TiCl2 and (Cp-R)CpTiCl2 (R = CO2CH3 and CO2CH2CH3), and three water-soluble titanocene–amino acid complexes—[Cp2Ti(aa)2]Cl2 (aa = l-cysteine, l-methionine, and d-penicillamine)—on the human colon adenocarcinoma cell line, HT-29. The capacity of [Ti4(maltolato)8(μ-O)4] to donate Ti(IV) to human apo-transferrin and its hydrolytic stability have been investigated and compared to the previously reported data on modified titanocenes with either hydrophilic ancillary ligands or the functionalized cyclopentadienyl ligands. Notably, the titanium–maltolato complex does not transfer Ti(VI) to human apo-transferrin at any time within the first seven days of its interaction, demonstrating the inert character of this species. Stability studies on these complexes have shown that titanocene complexes decompose at physiological pH while the [Ti4(maltolato)8(μ-O)4] complex is stable at this pH without any notable decomposition for a period of ten days. The antitumor activity of these complexes against colon cancer HT-29 cells was determined using an MTT cell viability assay at 72 and 96 h. The titanocene–amino acid and the (Cp-R)2TiCl2/(Cp-R)CpTiCl2 (R = CO2CH3) complexes were not biologically active when human transferrin was absent; they also were inactive when human transferrin was present at dose-equivalent concentrations. (Cp-R)2TiCl2 and (Cp-R)CpTiCl2 (R = CO2CH2CH3) showed cytotoxic activity in HT-29 cells comparable to that which is displayed by titanocene dichloride. The titanium–maltolato complex had higher levels of cytotoxic activity than any other titanocene complex investigated. Transferrin may be important in protecting the titanium center from hydrolysis, but this may be achieved by selecting ligands that could result in hydrolytically stable, yet active, complexes.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Scheme 1
Scheme 2
Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  1. Köpf-Maier P (1994) Eur J Clin Pharmacol 47:1

    Article  PubMed  Google Scholar 

  2. Köpf-Maier P, Köpf H (1988) Struct Bonding 70:103

    Google Scholar 

  3. Köpf-Maier P, Köpf H (1987) Chem Rev 87:1137

    Article  Google Scholar 

  4. Köpf-Maier P, Köpf H (1994) In: Fricker SP (ed) Metal compounds in cancer therapy, organometallic titanium, vanadium, niobium, molybdenum and rhenium complexes—early transition metal antitumor drugs. Chapman & Hall, London, pp 109–146

  5. Harding MM, Mokdsi G (2000) Curr Med Chem 7:1289

    PubMed  CAS  Google Scholar 

  6. Meléndez E (2002) Crit Rev Oncol Hematol 42:309

    Article  PubMed  Google Scholar 

  7. Toney JH, Marks TJ (1985) J Am Chem Soc 107:947

    Article  CAS  Google Scholar 

  8. Boyles JR, Baird MC, Campling BG, Jain N (2001) J Inorg Biochem 84:159

    Article  PubMed  CAS  Google Scholar 

  9. Valadares MC, Klein SL, Guaraldo AMA, Queiroz MLS (2003) Eur J Pharmacol 473:191

    Article  PubMed  CAS  Google Scholar 

  10. Allen OR, Croll L, Gott AL, Knox RJ, McGowan PC (2004) Organometallics 23:288

    Article  CAS  Google Scholar 

  11. Causey PW, Baird MC, Cole SPC (2004) Organometallics 23:4486

    Article  CAS  Google Scholar 

  12. Tacke M, Allen LT, Cuffe L, Gallagher WM, Lou Y, Mendoza O, Mueller-Bunz H, Rehmann F-JK, Sweeney N (2004) J Organomet Chem 689:2242

    Article  CAS  Google Scholar 

  13. Rehmann F-JK, Cuffe LP, Mendoza O, Rai DK, Sweeney N, Strohfeldt K, Gallagher WM, Tacke M (2005) Appl Organomet Chem 19:293

    Article  CAS  Google Scholar 

  14. Sweeney NJ, Mendoza O, Müller-Bunz H, Pampillón C, Rehmann F-JK, Strohfeldt K, Tacke M (2005) J Organomet Chem 690:4537

    Article  CAS  Google Scholar 

  15. Gansäuer A, Franke D, Lauterbach T, Nieger M (2005) J Am Chem Soc 127:11622

    Article  PubMed  Google Scholar 

  16. Kelter G, Sweeney NJ, Strohfeldt K, Fiebig H-H, Tacke M (2005) Anti Cancer Drugs 16:1091

    Article  PubMed  CAS  Google Scholar 

  17. Valadares MC, Ramos AL, Rehmann F-JK, Sweeney NJ, Strohfeldt K, Tacke M, Queiroz MLS (2006) Eur J Pharmacol 534:264

    Article  PubMed  CAS  Google Scholar 

  18. Fichtner I, Pampillon C, Sweeney NJ, Strohfeldt K, Tacke M (2006) Anti Cancer Drugs 17:333

    Article  PubMed  CAS  Google Scholar 

  19. Meléndez E, Marrero M, Rivera C, Hernández E, Segal A (2000) Inorg Chim Acta 298:176

    Article  Google Scholar 

  20. Pérez Y, López V, Rivera-Rivera L, Cardona A, Meléndez E (2005) J Biol Inorg Chem 10:94

    Article  PubMed  Google Scholar 

  21. Gao L, Hernández R, Matta J, Meléndez E (2007) J Biol Inorg Chem 12:959

    Article  PubMed  CAS  Google Scholar 

  22. Guo M, Sun H, McArdle HJ, Gambling L, Sadler PJ (2000) Biochemistry 39:10023

    Article  PubMed  CAS  Google Scholar 

  23. Messori L, Orioli P, Banholer V, Pais I, Zatta P (1999) FEBS Lett 422:157

    Article  Google Scholar 

  24. US Patent application number 60987915. 14 November, 2007

  25. Lamboy JL, Pasquale A, Rheingold AL, Meléndez E (2007) Inorg Chim Acta 360:2115

    Article  CAS  Google Scholar 

  26. Harstrick A, Schmoll H-J, Sass G, Poliwoda H, Rustum Y (1993) Eur J Cancer 29A:1000

    Article  PubMed  CAS  Google Scholar 

  27. Kurbacher CM, Bruckner HW, Andreotti PE, Kurbacher JA, Saβ G, Krebs D (1995) Anti Cancer Drugs 6:697

    Article  PubMed  CAS  Google Scholar 

  28. Rehmann F-J, Rous AJ, Mendoza O, Sweeney NJ, Strohfeldt K, Gallagher WM, Tacke M (2005) Polyhedron 24:1250

    Article  CAS  Google Scholar 

  29. Pampillón C, Sweeney NJ, Strohfeldt K, Tacke M (2007) J Organomet Chem 692:2153

    Article  Google Scholar 

  30. Mossman T (1983) J Immunol Methods 65:55

    Article  Google Scholar 

  31. Denizot F, Lang R (1986) J Immunol Methods 89:271

    Article  PubMed  CAS  Google Scholar 

  32. Caruso F, Rossi M (2004) Mini Rev Med Chem 4:49

    Article  PubMed  CAS  Google Scholar 

  33. Caruso F, Rossi M, Tanski J, Sartori R, Sariego R, Moya S, Diez S, Navarrete E, Cingolani A, Marchetti F, Pettinari C (2000) J Med Chem 43:3665

    Article  PubMed  CAS  Google Scholar 

  34. Keppler BK, Friesen C, Moritz HG, Vongerichten H, Vogel E (1991) Struct Bonding 78:98

    Google Scholar 

Download references

Acknowledgments

Enrique Meléndez acknowledges the NIH-MBRS SCORE Programs at both the University of Puerto Rico Mayagüez and the Ponce School of Medicine for financial support via NIH-MBRS-SCORE Program grant #S06 GM008239-23 and the PSM-Moffitt Cancer Center Partnership 1U56CA126379-01. In addition, Enrique Meléndez thanks the NSF-MRI Program for providing funds for the purchase of the 500 MHz NMR instrument and to the Sloan Foundation for financial support in the form of a graduate fellowship to Ramón Hernández. Finally, Jaime Matta would like to thank Bob Ritchie, RCMI Program Grant #RR003050-23, for his help in the editing of this manuscript.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Enrique Meléndez.

Electronic supplementary material

Below is the link to the electronic supplementary material.

Supplementary Material (PDF 203 kb)

Rights and permissions

Reprints and permissions

About this article

Cite this article

Hernández, R., Lamboy, J., Gao, L.M. et al. Structure–activity studies of Ti(IV) complexes: aqueous stability and cytotoxic properties in colon cancer HT-29 cells. J Biol Inorg Chem 13, 685–692 (2008). https://doi.org/10.1007/s00775-008-0353-z

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00775-008-0353-z

Keywords

Navigation